This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) | MicrobiomeTrials
← Back to trials NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-04-10Est. Completion: 2028-07-25
Enrollment target: 680 participantsLocations Valkyrie Clinical Trials, Los Angeles, California, United States Los Angeles Cancer Network, Los Angeles, California, United States Pih Health Hematology Medical Oncology, Whittier, California, United States Orchard Healthcare Research Inc, Skokie, Illinois, United States M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States NYU Langone Health, New York, New York, United States Icahn School of Medicine At Mount Sinai Prime, New York, New York, United States Clinical Research Alliance, Inc, Westbury, New York, United States White Plains Hospital, White Plains, New York, United States Erlanger Health, Inc, Chattanooga, Tennessee, United States The West Clinic, Germantown, Tennessee, United States SCRI Oncology Partners, Nashville, Tennessee, United States Texas Oncology - West Texas, Amarillo, Texas, United States Texas Oncology, P.A., Dallas, Texas, United States Texas Oncology Gulf Coast, Pearland, Texas, United States Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States Other microbiome trials you might be interested in Recurrent Breast Carcinoma Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7
This randomized phase II trial studies how well tamoxifen citrate works compared with z-endoxifen hydrochloride in treat…
Mobile, United States Est. completion Nov 6, 2020
Clinical Stage III Cutaneous Melanoma AJCC v8
Virginia Cancer Specialists, Fairfax, Virginia, United States
Wenatchee Valley Hospital and Clinics, Wenatchee, Washington, United States
Centro de Investigaciones Medicas Mar Del Plata, Mar del Plata, Buenos Aires, Argentina
Hospital Aleman, Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina
Hospital Sirio Libanes, Caba, Ciudad Autonoma Buenos Aires, Argentina
DIABAID, Buenos Aires, Argentina
Centro Médico Austral, Ciudad Autonoma Buenos Aires, Argentina
Centro de Investigaciones Medicas y Desarrollo LC SRL LC Investigacion, Ciudad Autonoma Buenos Aires, Argentina
Blacktown Hospital, Blacktown, New South Wales, Australia
St Vincent'S Hospital Sydney, Mount Kuring-Gai, New South Wales, Australia
Genesiscare North Shore Oncology, St Leonards, New South Wales, Australia
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
St John of God Subiaco Hospital, Subiaco, Western Australia, Australia
Cliniques Universitaires Saint-Luc, Brussels, Belgium
Grand Hospital de Charleroi, Charleroi, Belgium
Universitair Ziekenhuis Gent, Ghent, Belgium
Uz Leuven, Leuven, Belgium
Chu de Liă Ge, Liège, Belgium
Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
Hospital São Lucas Da Pucrs, Porto Alegre, Rio Grande do Sul, Brazil
Cepon - Centro de Pesquisas Oncolă"Gicas de Santa Catarina, Florianópolis, Santa Catarina, Brazil
Hospital de Câncer de Barretos - Fundação Pio XII, Barretos, São Paulo, Brazil
Centro de Pesquisas Clinicas da Fundação Doutor Amaral Carvalho, Jaú, São Paulo, Brazil
Biocenter, Concepción, Biobio, Chile
Centro Del Cancer UC, Santiago, Santiago Metropolitan, Chile
Clinica Redsalud Vitacura, Santiago, Santiago Metropolitan, Chile
Ic La Serena Research, La Serena, Chile
James Lind Centro de Investigacion Del Cancer, Temuco, Chile
Centre Georges François Leclerc, Dijon, Cote dÝOr, France
Hopital Saint Andre, Bordeaux, Gironde, France
Institut Bergonié, Bordeaux, Gironde, France
Institut Régional Du Cancer de Montpellier, Montpellier, Herault, France
CRLCC Eugene Marquis, Rennes, Ille Et Vilaine, France
Ico - Site René Gauducheau, Saint-Herblain, Loire Atlantique, France
Institut Curie - Site de Paris, Paris, Paris, France
Centre Léon Bérard, Lyon, Rhone, France
GustaveRoussy DptPharmacie, Villejuif, Val De Marne, France
Chu Besançon - Hôpital Jean Minjoz, Besançon, France
Institut Claudius Regaud, Toulouse, France
Universitaetsklinikum Heidelberg, Heidelberg, Baden-Wurttemberg, Germany
Slk-Kliniken Heilbronn Gmbh, Heilbronn, Baden-Wurttemberg, Germany
Universitätsklinikum Münster, Medizinische Klinik A, Münster, North Rhine-Westphalia, Germany
Univ der Johannes GutenbergU, Mainz, Rhineland-Palatinate, Germany
Staedtisches Klinikum Dresden Standort Dresden-Friedrichstadt, Dresden, Saxony, Germany
Universitäres Krebszentrum Leipzig UCCL, UKL AöR, Leipzig, Saxony, Germany
Vivantes Klinikum Neukoelln, Berlin, Germany
Charită - Campus Charită Mitte, Berlin, Germany
St Vincent'S University Hospital, Dublin, Dublin, Ireland
Cork University Hospital, Cork, Ireland
Mater Misericordiae University Hospital, Dublin, Ireland
Tallaght University Hospital, Dublin, Ireland
University Hospital Galway, Galway, Ireland
Fondazione Del Piemonte Per L'Oncologia Irccs Candiolo, Candiolo, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda), Milan, Italy
Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Istituto Clinico Humanitas, Rozzano, Italy
Aichi Cancer Center Hospital, Nagoya, Aichi-ken, Japan
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
Kindai University Hospital, Ōsaka-sayama, Osaka, Japan
Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka, Japan
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
The Cancer Institute Hospital of Jfcr, Koto-ku, Tokyo, Japan
Saitama Cancer Center, Saitama, Japan
Medical Care & Research Sa de Cv, Mérida, Mexico
Centro de Atenciă"N E Investigaciă"N Clă Nica En Oncologă A, Mérida, Mexico
Cryptex Investigacion Clinica S.A. de C.V., México, Mexico
Amsterdam Umc, Locatie Vumc, Amsterdam, Netherlands
Universitair Medisch Centrum Groningen, Groningen, Netherlands
Radboudumc Nijmegen, Nijmegen, Netherlands
Erasmus Medisch Centrum, Rotterdam, Netherlands
Umc Utrecht, Utrecht, Netherlands
SPZOZ Szpital Uniwer w Krakowie, Krakow, Poland
Instytut MSF Sp. z o.o., Lodz, Poland
MRUK-MED i Spółka z ograniczoną odpowiedzialnością, Rzeszów, Poland
Mazowiecki Szpital Wojewodzki W Siedlcach Sp Z O O, Siedlce, Poland
Aidport Sp Z O.O., Skorzewo, Poland
Instituto Portuguă S de Oncologia de Lisboa Francisco Gentil, Epe, Lisbon, Portugal
Fundação Champalimaud, Lisbon, Portugal
Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal
Centro Hospitalar Universitario de Santo Antonio, Porto, Portugal
Inst Portude Onco do Porto, Porto, Portugal
Hospital Universitari Vall D'Hebron, Barcelona, Spain
Hospital Clinic de Barcelona, Barcelona, Spain
ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona, Spain
Hospital General Universitario Gregorio Marañon, Madrid, Spain
Hospital Clínico San Carlos, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitario La Paz, Madrid, Spain
Hospital Universitario Virgen Macarena, Seville, Spain
China Medical University Hospital, Taichung, Taiwan
National Cheng Kung University Hospitalx, Tainan, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Taipei Veterans General Hospital, Taipei, Taiwan
Koo Foundation Sun Yat-Sen cancer center, Taipei, Taiwan
Tri-Service General Hospital, Taipei, Taiwan
Medipol Mega University Hospital, Bağcılar, Istanbul, Turkey (Türkiye)
Gulhane Training and Research Hospital, Ankara, Turkey (Türkiye)
Gazi University Medical Faculty, Ankara, Turkey (Türkiye)
Ankara City Hospital, Ankara, Turkey (Türkiye)
Ankara University Cebeci Hospital, Ankara, Turkey (Türkiye)
Izmir Medicalpark Hospital, Izmir, Turkey (Türkiye) Clinical Stage IV Cutaneous Melanoma AJCC v8
Metastatic Melanoma
Recurrent Melanoma
Unresectable Melanoma
This phase III trial studies how well initial treatment with ipilimumab and nivolumab followed by dabrafenib and trameti…
Birmingham, United States Est. completion Sep 30, 2023
Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Paranasal Sinus Neoplasms Nasopharyngeal Carcinoma Oropharyngeal Squamous Cell Carcinoma Hypopharyngeal Cancer Carcinoma of Larynx Oral Squamous Cell Carcinoma Salivary Gland Cancer Adenoid Cystic Carcinoma Prostate Cancer Metastatic Castration Resistant Prostate Cancer
Background:
Head and neck cancers (HNCs) account for about 5% of all cancers worldwide. They grow in the mouth, throat,…
Bethesda, United States Est. completion Oct 1, 2036